Literature DB >> 2471693

Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients.

U Bergmann1, J Scheffer, M Köller, W Schönfeld, G Erbs, F E Müller, W König.   

Abstract

Clinical isolates of Pseudomonas aeruginosa from severely burned patients were analyzed with regard to their capacity to induce inflammatory-mediator release from rat mast cells or human granulocytes. The bacterial strains were characterized according to their cell-associated hemolysin activity as well as their secreted hemolysin and phospholipase C activities. P. aeruginosa expressing heat-labile hemolysin and phospholipase C induced histamine release from rat mast cells and leukotriene formation from human granulocytes, while bacterial strains expressing heat-stable hemolysin were potent releasers of histamine but did not lead to leukotriene formation. The mediator-inducing capacity was dependent on the growth characteristics of the bacterial strains. The purified glycolipid (heat-stable hemolysin) of P. aeruginosa was a potent inducer of histamine release but did not initiate leukotriene formation. Exotoxin A did not affect inflammatory-mediator release. P. aeruginosa with leukotriene-inducing capacity also enhanced omega oxidation of endogenous leukotriene B4, suggesting an additional inactivation of the chemotactic potential. Our data suggest that both hemolysins of P. aeruginosa contribute to the pathogenicity of P. aeruginosa by inducing and modulating inflammatory-mediator release from various cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471693      PMCID: PMC313859          DOI: 10.1128/iai.57.7.2187-2195.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Effects of ibuprofen on a pig Pseudomonas ARDS model.

Authors:  C C Lee; H J Sugerman; J L Tatum; T P Wright; P D Hirsh; J I Hirsch
Journal:  J Surg Res       Date:  1986-05       Impact factor: 2.192

2.  The role of exoenzyme S in infections with Pseudomonas aeruginosa.

Authors:  T I Nicas; J Bradley; J E Lochner; B H Iglewski
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

3.  Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia.

Authors:  S T Hingley; A T Hastie; F Kueppers; M L Higgins; G Weinbaum; T Shryock
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

Review 4.  Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.

Authors:  G B Pier
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

5.  Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes.

Authors:  K D Bremm; W König; P Pfeiffer; I Rauschen; K Theobald; M Thelestam; J E Alouf
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

6.  Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells.

Authors:  J Scheffer; W König; J Hacker; W Goebel
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.

Authors:  W Engels; J Endert; M A Kamps; C P van Boven
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

8.  Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract.

Authors:  D O Sordelli; M C Cerquetti; A Morris Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

9.  Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.

Authors:  D E Woods; M S Schaffer; H R Rabin; G D Campbell; P A Sokol
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 11.677

10.  Biochemical and genetic studies of iron-regulated (exotoxin A) and phosphate-regulated (hemolysin phospholipase C) virulence factors of Pseudomonas aeruginosa.

Authors:  M L Vasil; R M Berka; G L Gray; O R Pavlovskis
Journal:  Antibiot Chemother (1971)       Date:  1985
View more
  17 in total

1.  Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.

Authors:  R H Lawrence; T C Sorrelli
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 2.  Microbial pathogenicity and host defense in burned patients--the role of inflammatory mediators.

Authors:  W König; B Schlüter; J Scheffer; M Köller
Journal:  Infection       Date:  1992       Impact factor: 3.553

3.  Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent.

Authors:  D J Meyers; R S Berk
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

4.  A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.

Authors:  M W Konstan; G Döring; S L Heltshe; L C Lands; K A Hilliard; P Koker; S Bhattacharya; A Staab; A Hamilton
Journal:  J Cyst Fibros       Date:  2014-01-17       Impact factor: 5.482

5.  Induction of inflammatory mediator release (serotonin and 12-hydroxyeicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa glycolipid.

Authors:  B König; U Bergmann; W König
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

Review 6.  Rhamnolipids: diversity of structures, microbial origins and roles.

Authors:  Ahmad Mohammad Abdel-Mawgoud; François Lépine; Eric Déziel
Journal:  Appl Microbiol Biotechnol       Date:  2010-03-25       Impact factor: 4.813

7.  Modulation of leukotriene generation by invasive bacteria.

Authors:  M Gröne; J Scheffer; W König
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

8.  Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells.

Authors:  P Friedl; B König; W König
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

9.  Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa.

Authors:  Tong-Jun Lin; Lauren H Maher; Kaede Gomi; Jeffrey D McCurdy; Rafael Garduno; Jean S Marshall
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis.

Authors:  R H Lawrence; T C Sorrell
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.